FDA looks to put the brakes on compounded GLP-1s After years of wide-open compounding, regulators say theyre ready to enforce limits and restore control over the fast-growing GLP-1 market
Even though these medications share the same active ingredient, they have different formulations, manufacturing processes, and approved indications, which affect pricing
When were treating an individual who has this dual diagnosis, they are leaving with two diagnoses that the treatment can sometimes work against one another, Ihlenfeld said
Known for its short-acting, precise effects, it enhances growth hormone pulses, which play a critical role in supporting muscle growth, fat loss, and improved recovery